SHAPING THE OF PHARMACY
EMERGING TREND TAKING CLINICAL TRIALS TO THE COMMUNITY
FUTURE
THE FUTURE OF CLINICAL TRIALS: HOW COMMUNITY PHARMACISTS ARE GETTING
INVOLVED By: Gerald E. Finken,
R.Ph., M.S., CEO, RxE2
A
s a pharmacist working in clinical trials for forty years, I have seen the range of issues the industry faces with every new drug. From that experience, I know that
the best way to resolve these problems is to involve community pharmacists. My company, RxE2, was founded for
this purpose and proposes a new paradigm that will simplify clinical trials, enhancing trial and patient outcomes. Streamlining the process using technological advances that enable independent pharmacists to participate in clinical trials makes sense, and it off ers a solution to the nagging crises that have plagued the industry for decades.
Traditional Clinical Trial Challenges T e traditional clinical trial model
struggles to recruit participants and oſt en cannot retain those patients it does attract. Ensuring medication compliance and adherence has been an ongoing challenge for clinics, especially those that don’t actively involve pharmacists. T e new Food and Drug Administration (FDA) mandate to increase diversity adds another layer of diffi culty because outside of their local pharmacist, many underrepresented populations have no relationship with a healthcare provider that they trust to help them understand clinical trials. In addition to this, many have confi ning social determinants of health
(SDoH) that have not been addressed by clinics and prevent participation. T ese SDoHs include clinics being too distant from patient homes, participants’ need for childcare, or a lack of time off from work. Additionally, many candidates do not have easy access to doctors or do not have a healthcare provider (HCP) at all. T ese limitations underscore the need for a new approach.
pharmacies fl ourish because of the trusted relationship with and understanding of their patients. Additionally, for many communities, the local pharmacist is their go-to HCP, making the livelihood of a pharmacist dependent upon being accessible to patients. Accessibility doesn’t just mean being conveniently located. T e ideal aspect of independent pharmacists working with RxE2 is availability, an appointment is never
“Pharmacists who participated in trials with RxE2 shared their excitement about the program. T ey found great value in the opportunity to provide more healthcare options to their patients, engage patients using their clinical expertise, and add a new revenue stream for their businesses.”
T e solution: Independent Pharmacies Independent pharmacies cannot exist
without being culturally aware and connected to the community. Local
needed; any patient can walk into a pharmacy and receive healthcare advice and counseling at no cost. T e ongoing relationship between patients and
THE LEADING VOICE FOR THE MISSOURI PHARMACIST |
MoRx.com 17
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48
